Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases
- PMID: 13509544
- DOI: 10.7326/0003-4819-48-2-389
Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases
Similar articles
-
Use of radioactive P-32 in treating skeletal metastases from carcinoma of the prostate.Grace Hosp Bul. 1959 Jul;37:43-53. Grace Hosp Bul. 1959. PMID: 14428612 No abstract available.
-
[On a case of cancer of the prostate with bone metastases and fibrinolysis].Sangre (Barc). 1959;30:472-7. Sangre (Barc). 1959. PMID: 14420870 French. No abstract available.
-
Circulating fibrinolysin in carcinoma of the prostate.Can J Surg. 1959 Jan;2(2):138-41. Can J Surg. 1959. PMID: 13608345 No abstract available.
-
Androgens and prostate cancer bone metastases: effects on both the seed and the soil.Endocrinol Metab Clin North Am. 2011 Sep;40(3):643-53, x. doi: 10.1016/j.ecl.2011.05.001. Endocrinol Metab Clin North Am. 2011. PMID: 21889726 Review.
-
When prostate cancer meets bone: control by wnts.Cancer Lett. 2007 Aug 18;253(2):170-9. doi: 10.1016/j.canlet.2006.12.040. Epub 2007 Apr 25. Cancer Lett. 2007. PMID: 17462819 Review.
Cited by
-
Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by haparin.J Clin Pathol. 1967 Mar;20(2):152-7. doi: 10.1136/jcp.20.2.152. J Clin Pathol. 1967. PMID: 5602506 Free PMC article.
-
[Blood platelets and coagulationactive plasma proteins. A short summary of their function and pathology].Blut. 1962 May;8:171-82. doi: 10.1007/BF01631173. Blut. 1962. PMID: 14469095 German. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources